Alterity Therapeutics ATHE
NASDAQ ATHE
$2.31 +0.01 (+0.43%)
As of: Nov 11, 2026 · 3:59 PM EST

Alterity Therapeutics (ATHE) EPS (Diluted) (2016 - 2018)

Updated

Alterity Therapeutics' EPS (Diluted) came in at -$946,318 for the year ended Jun 30, 2026, compared with -$14,594 a year earlier.

Analysis

Alterity Therapeutics (ATHE) EPS (Diluted) (2016 - 2018) Analysis & Trends

Going back to the year ended Aug 31, 2020, Alterity Therapeutics' EPS (Diluted) data covers 7 years.

  • The figure for the year ended Jun 30, 2026 represents the lowest annual EPS (Diluted) in data going back to the year ended Aug 31, 2020.
  • Per Business Quant, earlier years put EPS (Diluted) at -$14,594 in the year ended Jun 30, 2025, $0.00 in the year ended Aug 29, 2024, $0.00 in the year ended Dec 31, 2023 and $0.05 in the year ended Jun 30, 2022 (-45.0%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 7.22
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 0.09
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.38
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.04
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 2.00
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 7.08
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 1.94
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 0.56
10 Alterity Therapeutics 42.05 Mn -41.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 -0.33
Dec 31, 2017 -0.24
Dec 31, 2016 -0.23
API Access

Alterity Therapeutics EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=ATHE&period=max&api_key=YOUR_API_KEY